Most Likely Diagnosis: Early or Evolving Iron Deficiency
This presentation most likely represents early iron deficiency (ID) or iron deficiency anemia (IDA) in evolution, and the appropriate work-up should prioritize serum ferritin and transferrin saturation to confirm iron deficiency, followed by investigation for the underlying cause.
Understanding the Laboratory Pattern
Your laboratory findings show a characteristic pattern:
- Low MCH (26.4 pg) and MCHC (30.5 g/dL): These indicate hypochromic red cells (cells with reduced hemoglobin content), which is the hallmark of iron deficiency 1
- Elevated RDW (19.3%): This reflects anisocytosis (variation in red cell size), which occurs early in iron deficiency as the body produces both normal and iron-deficient cells simultaneously 1
- Normal MCV: This is critical—microcytosis may be absent in early or combined deficiency, and a raised RDW can help recognize iron deficiency even when MCV remains normal 1
- Elevated platelet count (479 × 10⁹/L): Reactive thrombocytosis commonly accompanies iron deficiency and chronic blood loss
- Normal hemoglobin and hematocrit: This indicates you are not yet anemic, but the red cell indices suggest iron-restricted erythropoiesis
Diagnostic Work-Up Algorithm
Step 1: Confirm Iron Deficiency
Measure serum ferritin immediately 1:
- Ferritin <30 μg/L confirms iron deficiency in the absence of inflammation 2
- Ferritin <12 μg/L is diagnostic of iron deficiency 1
- If ferritin is 30-100 μg/L with concurrent inflammation, measure transferrin saturation <30% to confirm functional iron deficiency 1
Step 2: Identify the Underlying Cause
Once iron deficiency is confirmed, investigate the source 1:
For adult men and postmenopausal women:
- Upper GI endoscopy with small bowel biopsies (to exclude celiac disease, which occurs in 2-3% of IDA cases) 1
- Colonoscopy or barium enema (dual pathology occurs in ~10% of cases) 1
- Exclude GI malignancy, angiodysplasia, inflammatory bowel disease, and NSAID use 1
For premenopausal women:
- Assess menstrual blood loss history
- If menstrual losses are not excessive, proceed with GI evaluation as above 1
For all patients:
- Detailed dietary history (though borderline deficient diets alone should not preclude full GI investigation) 1
- Medication history: NSAIDs, aspirin, anticoagulants 1
- Family history of hemoglobinopathies, bleeding disorders, or telangiectasia 1
Step 3: Consider Alternative or Coexisting Diagnoses
If ferritin is normal or elevated (>100 μg/L), consider 3, 2:
- Thalassemia trait: Usually presents with elevated RBC count, which you don't have, but hemoglobin electrophoresis may be warranted if ethnicity suggests risk 1
- Anemia of chronic disease: Check CRP/ESR for inflammation 2
- Combined deficiency: Check vitamin B12 and folate levels, as combined deficiencies can normalize MCV while elevating RDW 1
Common Pitfalls to Avoid
Do not assume normal hemoglobin excludes iron deficiency: Your indices clearly show iron-restricted erythropoiesis despite normal hemoglobin 1
Do not rely solely on MCV: Normal MCV does not exclude iron deficiency—the combination of low MCH, low MCHC, and high RDW is highly suggestive 1, 2, 1
Do not skip GI evaluation based on dietary history alone: Even with identified dietary insufficiency, full GI investigation is required to exclude malignancy and other serious pathology 1
Do not overlook celiac disease: Small bowel biopsies during upper endoscopy are essential, as 2-3% of IDA patients have celiac disease 1
Reactive thrombocytosis should not distract from the primary diagnosis: Elevated platelets commonly accompany iron deficiency and chronic blood loss
Treatment Considerations
Once iron deficiency is confirmed 4:
- Initiate oral iron supplementation (ferrous sulfate, fumarate, or gluconate) while awaiting GI evaluation results
- Reassess hemoglobin and iron indices at 4 weeks to confirm response
- If oral iron is not tolerated or ineffective, consider intravenous iron 4
- Treat any identified underlying cause (e.g., gluten-free diet for celiac disease, endoscopic treatment of angiodysplasias) 4